Navigation Links
GenVec Reports Inducement Award
Date:5/25/2012

GAITHERSBURG, Md., May 25, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) announced today that on May 23, 2012 it granted an option to purchase shares of its common stock to Cynthia Collins, its newly appointed President and Chief Executive Officer.  The option grant was approved by the Compensation Committee of GenVec's Board of Directors and the Board of Directors, and was made as an inducement material to Ms. Collins's acceptance of employment with GenVec in accordance with NASDAQ Listing Rule 5635(c)(4).

The option allows for the purchase of up to 250,000 shares of GenVec's common stock at an exercise price per share equal to $2.54, the closing price of the Company's common stock on May 23, 2012.  The option has a ten-year term and will vest and become exercisable as to one-eighth (1/8th) of the shares of common stock covered by the option on the six month anniversary of the grant date and, on the first day of each month thereafter, the option will vest and become exercisable as to an additional one-forty-eighth (1/48th) of the shares of common stock covered by the option until the option is fully exercisable.

On May 24, 2012, GenVec filed a Form 8-K regarding the appointment of Ms. Collins and related matters.  Please refer to that filing for a full description of the inducement award agreement pursuant to which the option was granted.  GenVec is providing this information in accordance with NASDAQ Listing Rule 5635(c)(4).

About GenVec
GenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product
'/>"/>

SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GenVec Appoints Cynthia Collins as President and CEO
2. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
3. GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012
4. Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc.
5. GenVec Extends Research Collaboration with Global Pharmaceutical Company
6. GenVec Reports Third Quarter 2011 Financial Results
7. GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011
8. GenVec to Present at Stifel Nicolaus 2011 Healthcare Conference
9. GenVec Reports Second Quarter 2011 Financial Results
10. GenVec Elects Adel A.F. Mahmoud and Edward M. Connor, Jr. to Board of Directors
11. GenVec to Host First Quarter 2011 Earnings Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... and ATLANTA , August 28, ... US Food and Drug Administration (FDA) cleared the MagVita TMS ... adult patients who have failed to receive satisfactory improvement from ... non-invasive technique for stimulating neural tissue in the part of ... The procedure has been proven safe and effective and MagVenture ...
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
... Asthma Medication Linked to Respiratory Improvement in NYC ... ... corticosteroids (ICS),antiinflammatory treatments often prescribed for asthma, may be beneficial,in preventing ... 2007, the 73rd annual international scientific assembly,of the American College of ...
... 24 Pharmasset, Inc.,(Nasdaq: VRUS ) has ... and,Drug Administration (FDA) for R7128 for the treatment ... a prodrug of PSI-6130, an oral cytidine,nucleoside analog ... Pharmasset,s collaboration with Roche. Pharmasset is currently,enrolling a ...
Cached Medicine Technology:Inhaled Steriods Used as Preventive Treatment Post 9/11 2Inhaled Steriods Used as Preventive Treatment Post 9/11 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 4R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 5
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... ... price on Zoom teeth whitening. For just $199, patients can currently receive a one ... traditional in-office teeth whitening procedures, but it includes a number of unique features that ...
(Date:8/28/2015)... ... August 28, 2015 , ... The newest therapy to ... available for general use any time soon, according to educational website Surviving Mesothelioma. ... that received orphan drug designation for mesothelioma last week from the FDA, will now ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... now consolidated as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in ... number of custodial files the PSC may receive for corporate employees involved in ...
(Date:8/28/2015)... ... 28, 2015 , ... An independent study recently conducted confirms ... of change to treatment recommendations and diagnosis. The 2015 return on investment (ROI) ... and analyzed WorldCare’s second opinion process. , The study reviewed cases across three ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:WorldCare International, Inc. Celebrates Findings of Independent ROI Study 2
... , ... poll, Supporting Iraq and Afghanistan Troops and Veterans, found two out of three Americans know ... and Afghanistan veterans and troops face. , ... Washington, DC (Vocus) May 10, 2010 -- A new public awareness poll, ...
... French . , Neurological research and clinical ... London and McGill University of Montreal entered an agreement ... field. Sir Keith O,Nions, Rector of Imperial, and Heather ... to sign the partnership documents, which will consolidate existing ...
... ... ... Clyburn will give the commencement address at the 135th Commencement ceremony for Meharry Medical College ... University in the Allen Arena. Doors open at 11:30 a.m., , , , ,Congressman Clyburn is ...
... show need for treatment even when pulmonary disease looks ... News) -- Worsening of chronic obstructive pulmonary disease (COPD) ... stroke, a new study finds. , British researchers looked ... in 426 patients and 633 ischemic strokes (blockage of ...
... help University of Central Florida researchers explore new ways ... and other neurological disorders. Stephen Lambert, an associate ... of UCF,s Hybrid Systems Laboratory, has received $428,000, the ... team will study the breakdown of myelin, a substance ...
... dyslexia often struggle with reading, writing, and spelling, despite ... other areas. New neurological research has found that these ... structural differences within an important information highway in the ... The findings are published in the June 2010 issue ...
Cached Medicine News:Health News:New Poll Finds Majority of Americans Are Unaware of Issues Facing Iraq/Afghanistan Veterans and Troops 2Health News:New Poll Finds Majority of Americans Are Unaware of Issues Facing Iraq/Afghanistan Veterans and Troops 3Health News:Trans-Atlantic agreement a boost to neuroscience research 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 3Health News:$1.9 million grant to help UCF find multiple sclerosis 'nerve-ana' 2Health News:Differences in language circuits in the brain linked to dyslexia 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: